The July 2012 NICHD Research Perspectives, the NICHD’s monthly podcast, is now online. This month’s podcast features research sponsored by the NICHD’s Pediatric, Adolescent and Maternal AIDS Branch.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Federal Report Shows Drops in Infant Mortality, Preterm Birth Rates
The infant mortality rate, the preterm birth rate, and the adolescent birth rate all continued to decline, average mathematics scores increased for 4th and 8th grade students, the violent crime victimization rate among youth fell, as did the percentage of young children living in a home where someone smoked, according to the federal government’s annual statistical report on the well-being of the nation’s children and youth.
Adding Nevirapine to HIV Regimen Halves Newborn Transmission Rate
Adding the drug nevirapine to the regimen given to newborns of women diagnosed with HIV shortly before or during labor halves the newborns' risk of contracting the virus, according to findings by a National Institutes of Health research network.
Health Benefits all Nations, HHS Secretary Tells NICHD Global Network
Secretary Sebelius addressed the researchers at the Network's Annual Steering Committee meeting this month. The Network, established by the NICHD and the Bill and Melinda Gates Foundation, seeks to prevent maternal and infant deaths and illnesses worldwide. Scientists from developing countries, together with those in the United States, lead teams that identify the health needs of an area and address those needs through randomized clinical trials to test treatments and interventions.
NIH Study of Spina Bifida Surgery Recognized as 'Trial of the Year'
The Society for Clinical Trials (SCT) has selected the NICHD Management of Myelomeningocele Study (MOMS) as its 'Trial of the Year.'
Anti-HIV Drug Use During Pregnancy does not Affect Infant Size, Birth Weight
Infants born to women who used the anti-HIV drug tenofovir as part of an anti-HIV drug regimen during pregnancy do not weigh less at birth and are not of shorter length than infants born to women who used anti-HIV drug regimens that do not include tenofovir during pregnancy, according to findings from a National Institutes of Health network study.
Video Presentation: Role of Research in Understanding, Preventing, & Treating Birth Defects
Item of Interest: Video Presentation: Role of Research in Understanding, Preventing, and Treating Birth Defects
Release of the 2011 Division of Intramural Research (DIR) Annual Report
The newly released 2011 DIR Annual Report reviews the latest basic, clinical, and translational research being pursued by the staff scientists within DIR at the NICHD. Contributing to this effort are 79 tenured and tenure-track investigators and approximately 1,200 administrative and research staff. In 2011, DIR project areas ranged from vaccine development to genomics, from reproduction to regenerative medicine, and from the neurosciences and early human development to biophysics and imaging.
High Animal Fat Diet Increases Gestational Diabetes Risk
Women who consumed a diet high in animal fat and cholesterol before pregnancy were at higher risk for gestational diabetes than women whose diets were lower in animal fat and cholesterol, according to researchers at the National Institutes of Health and Harvard University.
Study Shows Additional Benefits of Progesterone in Reducing Preterm Birth Risk
An analysis of five previous studies has uncovered additional evidence of the effectiveness of progesterone, a naturally occurring hormone, in reducing the rate of preterm birth among a high-risk category of women.
NIH Scientist who Advanced Understanding of Preeclampsia Passes Away
An NIH scientist whose landmark collaborations led to a major advance in understanding a potentially fatal disorder of pregnancy has passed away.
Progesterone Reduces Rate of Early Preterm Birth in at Risk Women
A National Institutes of Health study has found that progesterone, a naturally occurring hormone, reduced the rate of preterm birth before the 33rd week of pregnancy by 45 percent among one category of at risk women.
NICHD Director’s Lecture Series: New Frontiers in Endometriosis
NICHD Director Alan E. Guttmacher, M.D., initiated the NICHD Director’s Lecture Series as a way to showcase cutting-edge science relevant to the Institute’s mission. The forum also enables staff and other attendees to interact with other nationally recognized scientists.
New Intramural Report Available
The Division’s research programs address topics ranging from molecular and cellular biology, genetics, and endocrine and genetic disorders, to physical biology, neurosciences, immunology, reproduction, and behavioral research. Its projects are organized around the theme of the orchestration of life by molecular messengers.
Vitamin C and E Supplements Do Not Reduce Risk for Blood Pressure Disorders of Pregnancy
Taking vitamin C and E supplements starting in early pregnancy does not reduce the risk for the hypertensive disorders and their complications that occur during pregnancy, according to a study by a National Institutes of Health research network.
The "PROMISE" of Research
On January 15, researchers funded by the National Institute of Allergy and Infectious Diseases (NIAID) and the NICHD launched the Promoting Maternal-Infant Survival Everywhere—or PROMISE—study.
AIDS Awareness Month and the NICHD
This December, the NICHD joins the international community in recognizing the 21st annual AIDS Awareness Month. Research by the NICHD, several partner Institutes at NIH, and other organizations has helped change the outlook for those with HIV/AIDS in the United States and abroad. While it is good to reflect on how far we’ve come, the NICHD keeps its focus on the many challenges that remain for the future.
Study Finds Link Between Preeclampsia & Reduced Thyroid Function
Women who experience preeclampsia, a serious complication of pregnancy, may have an increased risk for reduced thyroid functioning later in life, report a team of researchers from the National Institutes of Health and other institutions.
Common Treatment to Delay Labor Decreases Preterm Infants' Risk for Cerebral Palsy
Preterm infants born to mothers receiving intravenous magnesium sulfate--a common treatment to delay labor--are less likely to develop cerebral palsy than are preterm infants whose mothers do not receive it, report researchers in a large National Institutes of Health research network.
NICHD-Supported Studies Offer Insight on Reducing Mother-to-Child HIV Transmission in Resource-Poor Countries
Each day, approximately 1,000 children—the majority of whom are newborns—become infected with HIV, according to the World Health Organization. HIV can be passed on during pregnancy or delivery, or even after the infant is born, through breastfeeding.